Stockreport

Sagimet Biosciences to Participate in Two Upcoming Investor Conferences

Sagimet Biosciences Inc.  (SGMT) 
PDF SAN MATEO, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatt [Read more]